Gilead, the biopharmaceutical company responsible for manufacturing Truvada, has come under scrutiny for its HIV drug pricing. This hour, we get the latest on this story. We also preview an upcoming Hartford rally, scheduled to coincide with AIDS Awareness Day.
Plus, for various reasons, a couple might decide to have their embryos frozen. But what happens to those embryos after the couple divorces? We learn about a state Supreme Court case, which centers on this very issue.
And finally, the SAT has a new score. An adversity score, to be more specific. We find out what this means and check in on Connecticut’s SAT requirements.
- Ed Silverman - Senior writer and Pharmalot columnist at STAT News
- Shawn Lang - Deputy Director of AIDS Connecticut (@shawnzo)
- Nicole Leonard - Health care reporter for WNPR/Connecticut Public Radio (@ACPressNLeonard)
- Nick Anderson - Covers higher education for The Washington Post (@wpnick)
- Kathy Megan - Covers education and child welfare for The Connecticut Mirror (@kathymegan)
Chion Wolf contributed to this show.